How to get Foundayo if you live in Canada

We wrote this page because the question lands in our inbox more than any other. Most of the guides explaining how to get Foundayo are written for Americans, and they make getting Foundayo sound like a five-minute telehealth visit. For someone with a US address, that is close to true. For someone in Winnipeg or Halifax, almost none of it applies. Let's break it down route by route, with the Canadian rule that decides each one.

One ground rule first. Nothing here is advice to obtain or take a medicine Health Canada has not authorised, and nothing here replaces a conversation with your own clinician. The point is to save you time, money and a bad day at the border.

How to get Foundayo: the short answer for Canadians

Here is every access route people ask us about, and where each one stands for a resident of Canada as of October 2026.

The rest of this page explains each row. If what you really want is a date for the Canadian decision, that lives on our orforglipron approval timeline, and the current regulatory picture sits on the Foundayo in Canada status page. We won't repeat either here.

Who can get Foundayo in the United States

It helps to know what the American route looks like, because that is what most articles on how to get Foundayo describe. The FDA approved Foundayo on 1 April 2026. The US prescribing information issued at approval lists one indication: alongside a reduced-calorie diet and more physical activity, to reduce excess body weight and keep it off long term in adults with obesity, or in adults with overweight who also have at least one weight-related condition. You can read that wording yourself in the FDA-approved Foundayo label.

A few things follow from that label. It is a prescription-only medicine, so every US patient still needs a licensed prescriber to say yes. It is for adults. The label also says using it together with another GLP-1 receptor agonist is not recommended, which matters if you are already on Ozempic, Wegovy or a similar drug. And it carries the thyroid C-cell tumour warning shared by the GLP-1 class; our orforglipron safety guide covers that properly.

How American patients actually get Foundayo

In the US there are three common paths. The first is the usual one: a family doctor or obesity specialist writes the prescription, and the patient fills it at a retail pharmacy, with or without insurance. The second is LillyDirect, Eli Lilly's own direct-to-patient service. LillyDirect does not write prescriptions. It sends a valid prescription to partner pharmacies for home delivery, and it points people without a prescriber toward independent telehealth providers. The third path is a telehealth company that employs its own clinicians, who assess the patient online and prescribe if they judge it appropriate.

Every one of those paths assumes a patient who lives in the United States. Lilly's published terms for Foundayo self-pay pricing and its savings card list, as a condition, that you are a resident of the United States or Puerto Rico and 18 years of age or older. The LillyDirect Foundayo terms are public if you want to check them. US pricing and coverage are their own topic; see our breakdown of what orforglipron costs rather than trusting a number quoted in a forum.

Our take: if you are a Canadian resident and a website happily signs you up for Foundayo with a Canadian address, that is not a loophole. It is a red flag. More on that below.

Why a US prescription won't get you Foundayo in Canada

This is the question we get most, usually phrased as "my cousin in Buffalo has a doctor, can they just write it and I fill it here?" The answer is no, for two separate reasons.

The first reason is the rule itself. Health Canada's guidance on personal importation (GUI-0116) says plainly that prescriptions issued abroad may not be filled in Canada, and that drugs prescribed in Canada should only be filled in Canada. A Canadian pharmacist will not, and should not, process a prescription from a US prescriber.

The second reason would apply even if the first did not. A Canadian pharmacy can only dispense drugs authorised for sale here, each with its own eight-digit Drug Identification Number (DIN). Orforglipron has no Canadian authorisation and no DIN. There is simply no Canadian Foundayo on any wholesaler's shelf for a pharmacist to order. Lilly's new drug submission, accepted in January 2026, appears on Health Canada's Submissions Under Review list, which is the public record of drugs that are filed but not approved.

Personal importation rules: what GUI-0116 actually says

If you live in Canada, the document that governs whether you can bring Foundayo home is Health Canada's Bringing health products into Canada for personal use (GUI-0116), last updated in July 2026. We read the current version before writing this. Here is the part that matters.

Residents of Canada are generally not allowed to bring prescription drugs into Canada. That covers carrying them across the border yourself and having them sent by mail or courier, including orders placed online.

The guidance then lists the situations where Health Canada may permit a resident to bring in a personal quantity, defined as a 90-day supply or a single course of treatment:

• Coming home with drugs that were prescribed and filled in Canada.
• Continuing a treatment that was required to be started while abroad, for you or someone in your care travelling with you.
• Belonging to a foreign-sponsored clinical trial.
• Being a recently landed immigrant or refugee who needs to continue treatment.

Read the second bullet closely, because people searching how to get Foundayo into Canada lean on it. "Required to be initiated while abroad" describes something like an infection treated in a US emergency room during a holiday. Choosing to start a long-term weight-management pill while visiting the US is a different thing. We would not bet on that argument at the border, and we don't think you should either.

What happens to non-compliant shipments

GUI-0116 states that health products found non-compliant during inspection will be refused entry or seized, and that Health Canada can recover the costs of storing, transporting or destroying seized goods from the importer. In plain terms: you can lose the medicine, lose what you paid for it, and get a bill on top.

Visitors are treated differently

The guidance does let visitors to Canada bring a personal quantity of a prescription drug for their own use, and people staying longer than three months may receive an extra 90-day supply by mail every three months, with proof of visitor status. That is why an American relative can arrive with their own Foundayo for a two-week stay. The same allowance does not extend to Canadian residents, which is the source of a lot of confusion online.

Crossing the border with medication

Suppose you were travelling and you have medication with you when you return. What do the border agencies expect? The Canada Border Services Agency's guide for returning residents, I Declare, says you must declare all goods acquired outside Canada, whether you carry them or have them shipped. For health products it sends travellers straight to GUI-0116, which is the rule we just walked through. CBSA can seize undeclared or falsely declared goods and may add a penalty based on their value.

For medicines you are allowed to carry, such as a prescription filled at your local pharmacy before a trip, the guidance asks that they stay in the pharmacy package, the original retail package, or carry the original label showing what the product is and what it contains. Bring a copy of the prescription or a note from your prescriber. Those habits make any trip smoother. They do not turn a drug that is unauthorised in Canada into one you are permitted to import.

Snowbirds ask about this a lot. If you split the year between Ontario and Arizona, your status still matters: a Canadian resident is treated as a resident. If your situation is genuinely unusual, ask Health Canada directly before you travel rather than relying on a border officer's discretion on the day.

The Special Access Program, and why it rarely fits here

Health Canada runs a Special Access Program (SAP) that lets a practitioner request a drug not sold in Canada for a specific patient. It is real, and it is often misunderstood. Here is how it works, based on Health Canada's own pages for patients and practitioners.

• Patients cannot apply. Only a health or dental practitioner, typically a physician with prescribing privileges in your province or territory, can submit a request.
• The bar is high. The program is for serious or life-threatening conditions where conventional therapies have failed, are unsuitable, or are unavailable in Canada. Health Canada describes it as intended for medical emergency situations.
• Alternatives count against you. Reviewers consider whether marketed alternatives are available. Canada already sells several GLP-1 medicines for weight and for type 2 diabetes.
• The maker must agree. Even an approved request goes nowhere unless the manufacturer chooses to supply. Health Canada says it cannot require them to.
• Someone pays. The manufacturer sets the price. A drug may be provided free or at a cost covered by a hospital, insurer, or the patient.

Put those together and you can see why we call this route rare for orforglipron. Obesity and type 2 diabetes are serious conditions, but a request has to explain why every authorised option is unsuitable or has failed. Whether that could ever describe your case is your doctor's call, not ours, and Health Canada's SAP information for patients is worth reading before you raise it.

Orforglipron clinical trials recruiting in Canada

A clinical trial is the one route to orforglipron that Health Canada's import rules name directly, and Lilly is still running large studies with Canadian sites. We searched the ClinicalTrials.gov registry for orforglipron studies recruiting in Canada on 5 October 2026. Three phase 3 trials came up.

Three things to know before you call a site. All three trials are double-blind and placebo-controlled, so you could spend the study on a dummy tablet without knowing it. Each has exclusion rules too, such as recent use of anti-obesity medicines in the incontinence study. And recruitment changes week to week, so treat our table as a starting point and check each listing's status and site contacts yourself.

Our honest view: join a trial because the question it asks matters to you, not as a back door to a prescription. If you qualify, the study team will explain the risks, the visit schedule and what happens when the trial ends.

Approved GLP-1 options you can get in Canada today

If the goal behind "how to get Foundayo" is really "how do I get a GLP-1 medicine," the answer in Canada is much better. These products are authorised by Health Canada and listed in its Drug Product Database, where you can confirm each DIN yourself.

Note the gap. The only GLP-1 pill sold here today, Rybelsus, is authorised for type 2 diabetes, not for weight management, and it comes with strict rules about food and water that Foundayo does not have. Our Foundayo vs Rybelsus comparison goes through those differences. Which of these options suits you, at what dose, and whether your provincial plan or private insurer will cover it, are questions for your prescriber and pharmacist. We deliberately give no dosing guidance here.

What to ask your doctor about getting Foundayo

You can still have a useful appointment about a drug your doctor cannot prescribe yet. Here are the questions we would bring.

• Based on my health, would a GLP-1 medicine make sense for me at all?
• Is one of the authorised options (Wegovy, Zepbound, or a diabetes medicine if I have type 2 diabetes) a reasonable start while orforglipron is under review?
• If I start an injection now, could I switch to a daily pill later if one is authorised for my condition?
• What does my provincial drug plan or workplace insurance cover today, and what paperwork would a special authority request need?
• Am I a fit for any recruiting orforglipron trial near me, and would you be comfortable with me joining?
• Is there any situation where you would consider a Special Access request, and what would you need to see first?

Bring a short list of medicines you already take, since GLP-1 drugs are not meant to be combined with each other. And if your doctor says no to all of it, ask why. A clear "not for you" is useful information too.

Counterfeit and unlicensed online sellers

Here is why this section exists. When a drug is famous and hard to get, fake versions appear fast. In January 2026, Health Canada issued a public advisory warning Canadians about fake or unauthorized GLP-1 products sold in stores and online, including tablets and injections. The advisory warns that these products may contain too much, too little or none of the active ingredient, hidden or dangerous ingredients, or contaminants such as heavy metals. It also flags websites and ads that misuse Health Canada logos and fake endorsements.

Apply that to Foundayo and the logic is simple. No authorised orforglipron exists in Canada. So any site offering to ship "Foundayo" or "orforglipron" to a Canadian address today is selling something Health Canada has not assessed, whatever the packaging says. Warning signs we see often:

• No prescription needed, or a "consultation" that is a three-question form.
• No eight-digit DIN on the product, or a DIN that does not appear in the Drug Product Database.
• "Research use only" labels, peptide shops, or powders sold for mixing.
• Health Canada or FDA logos used as a badge of approval.
• Payment by crypto, gift cards or wire transfer only.

Health Canada's advice is to buy prescription drugs only from licensed pharmacies, check the DIN, and report suspected counterfeits to the department. We would add one more: if a price or a shortcut seems too good, it usually is.

Next steps

So, how to get Foundayo as a Canadian? For most people the honest plan has three parts: talk to your doctor about authorised options now, check whether a Canadian trial fits you, and wait for Health Canada's decision rather than gambling on the border. The next published step we are tracking is expert committee meets on weight management, scheduled for October 28, 2026.

Our Canadian orforglipron tracker logs every regulatory step with a date and a source, and our approval alerts will email you when the Notice of Compliance lands. When that day comes, this page will change from "here is why you can't" to "here is how," and we will update it the same week.